These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25271470)

  • 1. Antibiotic resistance--problems, progress, and prospects.
    Nathan C; Cars O
    N Engl J Med; 2014 Nov; 371(19):1761-3. PubMed ID: 25271470
    [No Abstract]   [Full Text] [Related]  

  • 2. A three-step plan for antibiotics.
    Nature; 2014 May; 509(7502):533. PubMed ID: 24877183
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving outpatient antibiotic prescribing for respiratory tract infections: results of new algorithms used in European trials.
    Gaynes R; Levy S
    Infect Control Hosp Epidemiol; 2015 Jun; 36(6):725-9. PubMed ID: 25736896
    [No Abstract]   [Full Text] [Related]  

  • 4. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective.
    Chopra I; Hodgson J; Metcalf B; Poste G
    JAMA; 1996 Feb; 275(5):401-3. PubMed ID: 8569021
    [No Abstract]   [Full Text] [Related]  

  • 5. The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes.
    Turner MJ
    Drug Discov Today; 2015 Aug; 20(8):917-9. PubMed ID: 26100736
    [No Abstract]   [Full Text] [Related]  

  • 6. The economics of resistant pathogens and antibiotic innovation.
    McKellar MR; Chernew ME; Fendrick AM
    Am J Manag Care; 2014 Mar; 20(3):193-7. PubMed ID: 24884749
    [No Abstract]   [Full Text] [Related]  

  • 7. Society must seize control of the antibiotics crisis.
    Amábile-Cuevas C
    Nature; 2016 May; 533(7604):439. PubMed ID: 27225081
    [No Abstract]   [Full Text] [Related]  

  • 8. Is the GAIN Act a turning point in new antibiotic discovery?
    Brown ED
    Can J Microbiol; 2013 Mar; 59(3):153-6. PubMed ID: 23540332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resisting the use of antibiotics for viral infections.
    Tanday S
    Lancet Respir Med; 2016 Mar; 4(3):179. PubMed ID: 26895654
    [No Abstract]   [Full Text] [Related]  

  • 10. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics: the changing regulatory and pharmaceutical industry paradigm.
    Bax R; Green S
    J Antimicrob Chemother; 2015 May; 70(5):1281-4. PubMed ID: 25634991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calculus of cures.
    Kocher R; Roberts B
    N Engl J Med; 2014 Apr; 370(16):1473-5. PubMed ID: 24571723
    [No Abstract]   [Full Text] [Related]  

  • 13. The drug-resistant bacteria that pose the greatest health threats.
    Willyard C
    Nature; 2017 Feb; 543(7643):15. PubMed ID: 28252092
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug and vaccine development for infectious diseases: the value of priority review vouchers.
    Matheny J; Smith B; Courtney B; Mair M
    Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial resistance needs action.
    While A
    Br J Community Nurs; 2012 Apr; 17(4):198. PubMed ID: 22848944
    [No Abstract]   [Full Text] [Related]  

  • 16. Do health plans have a role in limiting antibiotic resistance?
    Burns J
    Manag Care; 2014 Apr; 23(4):26-30, 32-3. PubMed ID: 24864530
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicines for rare (orphan) diseases: an enquiry and proposal for tax-incentives.
    John JE
    Drug Discov Today; 2011 Dec; 16(23-24):999-1000. PubMed ID: 22020052
    [No Abstract]   [Full Text] [Related]  

  • 18. Wiser prescribing.
    Bell H
    Minn Med; 2012 Aug; 95(8):10-2. PubMed ID: 22953467
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical infectiology--I. Diagnosis, pathogen spectrum and resistance].
    Schrappe M
    Med Klin (Munich); 1996 Apr; 91 Suppl 1():166-75. PubMed ID: 8657083
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicine. Can intellectual property save drug development?
    FitzGerald GA
    Science; 2012 Oct; 338(6106):483-4. PubMed ID: 23112323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.